NMRA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Neumora Therapeutics Inc (NMRA).


$1.71B Market Cap.

As of 03/04/2025 5:00 PM ET (MRY) • Disclaimer

NMRA Market Cap. (MRY)


NMRA Shares Outstanding (MRY)


NMRA Assets (MRY)


Total Assets

$316.97M

Total Liabilities

$29.91M

Total Investments

$165.43M

NMRA Income (MRY)


Revenue

$0

Net Income

-$243.79M

Operating Expense

$263.46M

NMRA Cash Flow (MRY)


CF Operations

-$182.94M

CF Investing

-$70.56M

CF Financing

$21.60M

NMRA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

-

0%

0%

-

2021

$0

-

-

0%

-

NMRA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$316,972,000 (-36.12%)

$496,195,000 (16.41%)

$426,234,000 (-0.71%)

$429,297,000

Assets Current

$314,055,000 (-34.34%)

$478,279,000 (23.28%)

$387,955,000 (-6.65%)

$415,603,000

Assets Non-Current

$2,917,000 (-83.72%)

$17,916,000 (-53.20%)

$38,279,000 (179.53%)

$13,694,000

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$287,064,000 (-38.80%)

$469,076,000 (204.97%)

-$446,850,000 (-37.40%)

-$325,221,000

Property Plant & Equipment Net

$2,917,000 (-57.47%)

$6,858,000 (-35.56%)

$10,642,000 (163.35%)

$4,041,000

Cash & Equivalents

$143,361,000 (-61.80%)

$375,251,000 (54.93%)

$242,206,000 (-40.83%)

$409,372,000

Accumulated Other Comprehensive Income

$62,000 (181.58%)

-$76,000 (90.18%)

-$774,000 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$165,430,000 (84.24%)

$89,789,000 (-41.87%)

$154,452,000 (0%)

$0

Investments Current

$165,430,000 (106.93%)

$79,944,000 (-38.95%)

$130,941,000 (0%)

$0

Investments Non-Current

$0 (0%)

$9,845,000 (-58.13%)

$23,511,000 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$3,307,000 (881.31%)

$337,000 (-95.28%)

$7,147,000 (336.06%)

$1,639,000

Accumulated Retained Earnings (Deficit)

-$947,221,000 (-34.66%)

-$703,434,000 (-50.46%)

-$467,509,000 (-38.89%)

-$336,605,000

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$1,853,000 (-64.58%)

$5,231,000 (-38.04%)

$8,442,000 (311.40%)

$2,052,000

Debt Current

$1,853,000 (-45.15%)

$3,378,000 (0.24%)

$3,370,000 (219.13%)

$1,056,000

Debt Non-Current

$0 (0%)

$1,853,000 (-63.47%)

$5,072,000 (409.24%)

$996,000

Total Liabilities

$29,908,000 (10.28%)

$27,119,000 (-7.75%)

$29,397,000 (19.21%)

$24,660,000

Liabilities Current

$29,886,000 (19.02%)

$25,111,000 (5.97%)

$23,697,000 (1.80%)

$23,278,000

Liabilities Non-Current

$22,000 (-98.90%)

$2,008,000 (-64.77%)

$5,700,000 (312.45%)

$1,382,000

NMRA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$62,537,000 (37.52%)

$45,475,000 (46.12%)

$31,121,000 (26.78%)

$24,547,000

Research & Development Expense

$200,927,000 (40.79%)

$142,719,000 (55.55%)

$91,749,000 (64.50%)

$55,776,000

Operating Expenses

$263,464,000 (4.51%)

$252,098,000 (85.54%)

$135,870,000 (-42.75%)

$237,323,000

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Income Tax Expense

$178,000 (-33.58%)

$268,000 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$243,787,000 (-3.33%)

-$235,925,000 (-80.23%)

-$130,904,000 (44.84%)

-$237,312,000

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$243,787,000 (-3.33%)

-$235,925,000 (-80.23%)

-$130,904,000 (44.84%)

-$237,312,000

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$243,787,000 (-3.33%)

-$235,925,000 (-80.23%)

-$130,904,000 (44.84%)

-$237,312,000

Weighted Average Shares

$159,377,000 (145.12%)

$65,021,000 (-69.54%)

$213,477,000 (24.25%)

$171,815,000

Weighted Average Shares Diluted

$159,377,000 (145.12%)

$65,021,000 (-69.54%)

$213,477,000 (24.25%)

$171,815,000

Earning Before Interest & Taxes (EBIT)

-$243,609,000 (-3.37%)

-$235,657,000 (-80.02%)

-$130,904,000 (44.84%)

-$237,312,000

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$263,464,000 (-4.51%)

-$252,098,000 (-85.54%)

-$135,870,000 (42.75%)

-$237,323,000

NMRA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$70,557,000 (-209.58%)

$64,387,000 (138.32%)

-$168,013,000 (-20464.63%)

-$817,000

Net Cash Flow from Financing

$21,603,000 (-90.69%)

$231,936,000 (100.39%)

$115,743,000 (-60.57%)

$293,507,000

Net Cash Flow from Operations

-$182,936,000 (-12.04%)

-$163,278,000 (-42.11%)

-$114,896,000 (-52.34%)

-$75,420,000

Net Cash Flow / Change in Cash & Cash Equivalents

-$231,890,000 (-274.29%)

$133,045,000 (179.59%)

-$167,166,000 (-176.94%)

$217,270,000

Net Cash Flow - Business Acquisitions and Disposals

-$775,000 (83.12%)

-$4,590,000 (64.69%)

-$13,000,000 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

-$69,782,000 (-201.00%)

$69,094,000 (144.72%)

-$154,502,000 (0%)

$0

Capital Expenditure

$0 (0%)

-$117,000 (77.10%)

-$511,000 (37.45%)

-$817,000

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Issuance (Purchase) of Equity Shares

$21,603,000 (-90.84%)

$235,740,000 (5419.55%)

$4,271,000 (23.12%)

$3,469,000

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$39,990,000 (131.96%)

$17,240,000 (107.76%)

$8,298,000 (94.15%)

$4,274,000

Depreciation Amortization & Accretion

$3,921,000 (-2.54%)

$4,023,000 (49.17%)

$2,697,000 (73.89%)

$1,551,000

NMRA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-69.00% (96.75%)

-2123.00% (-6362.54%)

33.90%

-

Return on Average Assets (ROAA)

-64.00% (-25.00%)

-51.20% (-67.32%)

-30.60%

-

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-145.20% (16.89%)

-174.70% (-11.77%)

-156.30%

-

Dividend Yield

0% (0%)

0%

-

-

Price to Earnings Ratio (P/E)

-6.93 (-47.50%)

-4.7

-

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

5.97 (7.50%)

5.55

-

-

Debt to Equity Ratio (D/E)

0.1 (79.31%)

0.06 (187.88%)

-0.07 (13.16%)

-0.08

Earnings Per Share (EPS)

-1.53 (57.85%)

-3.63 (-495.08%)

-0.61 (55.80%)

-1.38

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-1.15 (54.32%)

-2.51 (-364.51%)

-0.54 (-21.85%)

-0.44

Book Value Per Share (BVPS)

1.8 (-75.03%)

7.21 (444.67%)

-2.09 (-10.57%)

-1.89

Tangible Assets Book Value Per Share (TABVPS)

1.99 (-73.94%)

7.63 (282.12%)

2 (-20.09%)

2.5

Enterprise Value Over EBIT (EV/EBIT)

-6 (33.33%)

-9

-

-

Enterprise Value Over EBITDA (EV/EBITDA)

-6 (36.70%)

-9.48

-

-

Asset Turnover

0 (0%)

0 (0%)

0

-

Current Ratio

10.51 (-44.83%)

19.05 (16.35%)

16.37 (-8.31%)

17.85

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$182,936,000 (-11.96%)

-$163,395,000 (-41.58%)

-$115,407,000 (-51.38%)

-$76,237,000

Enterprise Value (EV)

$1,438,365,278 (-34.51%)

$2,196,237,538

-

-

Earnings Before Tax (EBT)

-$243,609,000 (-3.37%)

-$235,657,000 (-80.02%)

-$130,904,000 (44.84%)

-$237,312,000

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$239,688,000 (-3.48%)

-$231,634,000 (-80.67%)

-$128,207,000 (45.62%)

-$235,761,000

Invested Capital

$145,578,000 (44.05%)

$101,064,000 (-40.12%)

$168,773,000 (13072.56%)

-$1,301,000

Working Capital

$284,169,000 (-37.29%)

$453,168,000 (24.41%)

$364,258,000 (-7.15%)

$392,325,000

Tangible Asset Value

$316,972,000 (-36.12%)

$496,195,000 (16.41%)

$426,234,000 (-0.71%)

$429,297,000

Market Capitalization

$1,712,547,278 (-34.22%)

$2,603,591,538

-

-

Average Equity

$353,401,000 (3080.07%)

$11,113,000 (102.88%)

-$386,035,500

-

Average Assets

$381,048,250 (-17.38%)

$461,214,500 (7.82%)

$427,765,500

-

Invested Capital Average

$167,786,250 (24.36%)

$134,918,500 (61.12%)

$83,736,000

-

Shares

161,561,064 (5.80%)

152,703,316 (11.27%)

137,239,096

-